The 3.5% Return This Week Takes Prestige Consumer Healthcare's (NYSE:PBH) Shareholders Five-year Gains to 120%
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put in. But when you pick a company that is really flourishing, you can make more
Prestige Consumer Healthcare to Release Fiscal 2025 First Quarter Earnings Results
PDF VersionTARRYTOWN, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2025 first quarter earnings release on Thursd
This Nike Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag
Express News | Prestige Consumer Healthcare Inc : D.a. Davidson Raises to Buy From Neutral
D.A. Davidson Upgrades Prestige Consumer Healthcare(PBH.US) to Buy Rating, Announces Target Price $93
D.A. Davidson analyst Linda Bolton Weiser upgrades $Prestige Consumer Healthcare(PBH.US)$ to a buy rating, and sets the target price at $93.According to TipRanks data, the analyst has a success rate o
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Business Is Trailing The Industry But Its Shares Aren't
It's not a stretch to say that Prestige Consumer Healthcare Inc.'s (NYSE:PBH) price-to-sales (or "P/S") ratio of 2.9x right now seems quite "middle-of-the-road" for companies in the Pharmaceuticals i
Prestige Consumer Healthcare (PBH) Down 0.4% Since Last Earnings Report: Can It Rebound?
Prestige Consumer Healthcare Inc. to Present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference
PDF Version TARRYTOWN, N.Y., June 06, 2024 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced it will present at the Oppenheimer Annual Consumer Growth and E-Commerc
Prestige Consumer Healthcare Inc.'s (NYSE:PBH) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Prestige Consumer Healthcare (NYSE:PBH) has had a rough month with its share price down 7.3%. But if you pay close attention, you might gather that its strong financials could mean that the stock co
Dramamine Ditches the 'Drama on Deck' With a Summer Sweepstakes Giving Away Two Private Yacht Charters
The #1 brand in motion related nausea relief teamed up with TV personality and former chief steward Kate Chastain to share how she keeps summer travel drama-freeTARRYTOWN, N.Y., May 22, 2024 /PRNewsw
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
Prestige Consumer Hlthcr Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Prestige Consumer, Maintains $80 Price Target
Prestige Consumer Healthcare: A Strong Buy Amid Solid Financials and Strategic Growth Initiatives
Prestige Consumer Hlthcr Price Target Maintained With a $65.00/Share by DA Davidson
Prestige Consumer Hlthcr Price Target Maintained With a $65.00/Share by DA Davidson
Express News | DA Davidson Maintains Neutral on Prestige Consumer, Maintains $65 Price Target
Prestige Consumer Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 -0.09% DA Davidson $65 → $65 Maintains Neutral 06/26/2023 -7.78% DA Davidson → $60 Reiterates N
Prestige Consumer (PBH) Q4 Earnings Miss, Operating Margin Falls
Prestige Consumer Healthcare Inc. PBH delivered fourth-quarter fiscal 2024 earnings per share (EPS) of $1.02, a 4.7% decline from the year-ago period’s figure. The metric also missed the Zacks Consensus Estimate by 10.5%.
Analysts Offer Insights on Healthcare Companies: Palatin Technologies (PTN), Prestige Consumer Healthcare (PBH) and CervoMed (CRVO)
Prestige Consumer Healthcare Inc (PBH) (Q4 2024) Earnings Call Transcript Highlights: ...
Prestige Consumer Healthcare Needs Even More Suppliers -- Market Talk
1443 ET - Prestige Consumer Healthcare's supply-chain strategy, which helped during pandemic-era disruptions, didn't stop issues in 4Q. CEO Ron Lombardi says on a call with analysts that the company's